Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research

Advanced Drug Delivery Reviews
M P Krafft

Abstract

The specific properties of fluorocarbons, exceptional chemical and biological inertness, high gas-dissolving capacity, low surface tension, excellent spreading characteristics and high fluidity, have triggered numerous applications of these compounds in oxygen delivery. An injectable emulsion of fluorocarbon-in-water destined to deliver oxygen to tissues at risk of hypoxia has now completed Phase III clinical trials in Europe. A neat fluorocarbon is currently investigated in Phase II for treatment of acute respiratory failure by liquid ventilation. Fluorinated lipids and fluorinated surfactants can be used to elaborate and stabilize various colloidal systems, including different types of emulsions, vesicles and tubules, that also show promise for controlled release drug delivery.

References

Oct 17, 1977·Biochimica Et Biophysica Acta·J N IsraelachviliB W Ninham
Jan 11, 1992·Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology·L C ClarkS L Davis
Jan 1, 1992·Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology·H MeinertW Röhlke
Jan 1, 1991·Journal of Biochemical Toxicology·J P Vanden HeuvelR E Peterson
Jan 1, 1988·Biomaterials, Artificial Cells, and Artificial Organs·Y TsudaY Saitoh
Aug 1, 1980·American Industrial Hygiene Association Journal·F A UbelD E Roach
Nov 4, 1995·Lancet·R B HirschlR H Bartlett
Jan 1, 1995·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·P E Keipert
Jan 1, 1995·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·B A Teicher
Sep 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·W L HolmanA D Pacifico
Jan 1, 1994·Journal of Drug Targeting·J G Riess
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·A Lattes, I Rico-Lattes
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·S F Flaim
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·S Rockwell
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·C CornélusJ G Riess
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·E SchuttT Pelura
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·O E OxynoidV V Obraztsov
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·V SanchezJ N Bruneton
Nov 1, 1994·Bioconjugate Chemistry·J S RemyJ P Behr
Jun 1, 1994·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J C MaurizisA Veyre
Jan 1, 1994·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·R F Mattrey
Feb 23, 1994·Biochimica Et Biophysica Acta·C SantaellaB Monasse
Jan 1, 1993·Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology·H Meinert, A Knoblich
Dec 28, 1993·FEBS Letters·C SantaellaJ G Riess
Mar 1, 1996·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Y NiD Song
Dec 20, 1996·Science·J B McClainR Triolo
Jan 1, 1997·Free Radical Biology & Medicine·J Everse, N Hsia
Sep 9, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·S RoccaM J Stébé

❮ Previous
Next ❯

Citations

Dec 21, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Luisa OttobriniGiovanni Lucignani
Jul 9, 2011·Pharmaceutical Research·Jun-Pil JeeSandro Mecozzi
Feb 28, 2009·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Jacob Raphael, Carl Lynch
May 25, 2005·Paediatric Respiratory Reviews·Marla R Wolfson, Thomas H Shaffer
Jan 28, 2009·Journal of the American Chemical Society·Ping JingShigeru Amemiya
Aug 14, 2009·Journal of the American Chemical Society·Laila DafikKrishna Kumar
Nov 5, 2011·The Journal of Physical Chemistry. B·Sun-Joo LeeNathan A Baker
Mar 17, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Chava PembertonNissim Garti
Jun 3, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Frederic TewesFrank Boury
Oct 20, 2006·Organic Letters·Eric J Mahan, Jennifer A Dennis
Aug 3, 2005·Chemical Communications : Chem Comm·P C GriffithsD W Knight
Apr 21, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hui-Fang ZhouChristine T N Pham
Apr 22, 2014·International Journal of Nanomedicine·Emeline J RibotPaula J Foster
Jan 16, 2014·Journal of the American Chemical Society·Hiroki TakezawaMakoto Fujita
Jun 10, 2008·The Journal of Chemical Physics·Flint PierceGary S Grest
Apr 10, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Heleen DewitteIne Lentacker
Aug 1, 2014·Future Medicinal Chemistry·Eva PrchalováMartin Kotora
Nov 9, 2006·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Jean G Riess
Mar 17, 2007·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Frédéric GerberThierry F Vandamme
Mar 10, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Anna Chachaj-BrekieszPatrycja Dynarowicz-Łątka
Apr 17, 2015·Chemistry : a European Journal·Steven BloomThomas Lectka
Jan 16, 2016·Therapeutic Delivery·Roberta CavalliMonica Argenziano
Jan 23, 2016·Nature Communications·Philipp GrunerJean-Christophe Baret
Oct 13, 2012·Journal of Colloid and Interface Science·Thi Huong Viet NgoRobert Coudert
Oct 18, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Florent PerretHélène Parrot-Lopez
Sep 27, 2012·Journal of Colloid and Interface Science·Paula ToimilFélix Sarmiento
Jan 13, 2010·Biophysical Chemistry·Eric A SmithPhoebe K Dea
Jun 30, 2009·Chemistry and Physics of Lipids·Hiroki YokoyamaOsamu Shibata
Jun 2, 2009·Journal of Colloid and Interface Science·Hiroki YokoyamaOsamu Shibata

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.